0156 Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

✍ Scribed by M. Gnant; B. Mlineritsch; W. Schippinger; G. Luschin-Ebengreuth; G. Steger; V. Bjelic-Radisic; R. Jakesz; E. Kubista; C. Marth; R. Greil

• Book ID: 114316293
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 57 KB
• Volume: 18
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(09)70187-0